menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    TAGRISSO® reaffirmed as key therapy for EGFR-mutated lung cancer

    BUSINESSWIRE

    Syneron Bio Announces Strategic Collaboration with AstraZeneca

    PR NEWSWIRE

    AstraZeneca investing $2.5 B in China

    REUTERS

    AstraZeneca signs Alteogen deal worth up to $1.35B

    FIERCE PHARMA

    AstraZeneca`s $800M rare disease bet hits primary Ph 3 goal

    FIERCE BIOTECH

    AstraZeneca boosts cancer therapies with $1B EsoBiotec buy

    REUTERS

    AstraZeneca approved to sell hyperkalaemia treatment in India

    ECONOMICTIMES

    Imfinzi Shows EFS Benefit In Early Gastric, GEJ Cancers

    BUSINESSWIRE

    AstraZeneca gets CDSCO approval to import, sell cancer medicine

    ECONOMICTIMES

    Tezspire Treats Chronic Sinus Symptoms With Nasal Polyps

    PR NEWSWIRE

    EU Backs AstraZeneca-Daiichi’s Enhertu for Breast Cancer

    REUTERS

    CHMP Recommends ENHERTU For HER2 Low/Ultralow Metastatic Breast Cancer

    BUSINESSWIRE

    AstraZeneca Posts Positive Ph 3 Results for Oral Breast Cancer Drug

    PRESS RELEASE

    TFS HealthScience Announces Leadership Transition: Katarina Agebo

    PR NEWSWIRE

    AstraZeneca boosts China presence with FibroGen`s anemia drug in $160M deal

    REUTERS

    FibroGen Sells China Business To AstraZeneca For $160M

    GLOBENEWSWIRE

    Astrazeneca Pharma India Net Profit Rises 95.25% In Q3

    BUSINESS STD

    Astrazeneca Pharma gains after Q3 PAT soars to Rs 55 cr

    BUSINESS STD

    AZ’s Alexion creates interactive storybook for kids with aHUS

    FIERCE PHARMA

    AIM Plans Study Of Ampligen® & FluMist® For Avian Influenza

    GLOBENEWSWIRE

    AstraZeneca CEO defends `fantastic` Alexion buy as halts drug

    FIERCE BIOTECH

    AstraZeneca shares rise as China probe update reassures

    REUTERS

    AstraZeneca`s Full Year and Q4 2024 results

    BUSINESSWIRE

    AstraZeneca shareholders say need clarity on China investigations

    REUTERS

    Erasmus Safety Committee Approves Ph 2 Study for Pancreatic Cancer

    GLOBENEWSWIRE

    UK hits back at AstraZeneca over collapse of investment deal

    REUTERS

    AZ scraps £450M vaccine plant expansion in the UK

    FIERCE PHARMA

    AstraZeneca ditches UK investment over cut in state support

    REUTERS

    Datopotamab Deruxtecan Recommended For Approval In EU By CHMP

    BUSINESSWIRE

    Tropion-Lung12 Phase 3 Trial Begins For Datroway In NSCLC

    BUSINESSWIRE

    Roche`s Itovebi pads its case with overall survival win

    REUTERS

    Enhertu Approved in US for HER2-Low/Ultralow Breast Cancer

    BUSINESSWIRE

    AstraZeneca Canadian investment to drive R&D growth

    EUROPEAN PHARMACEUTICAL REVIEW

    AstraZeneca receives recommendations for lung cancer treatments

    PHARMATIMES

    FDA Approves Acalabrutinib for Mantle Cell Lymphoma

    PRESS RELEASE

    CDSCO approves AstraZeneca’s anti-complement medicine

    EXPRESSPHARMA

    Datopotamab Deruxtecan Gets Priority Review For NSCLC Treatment

    BUSINESSWIRE

    Synthego & AstraZeneca Sign CRISPR Gene Editing Enzyme Deal

    CONTRACTPHARMA

    J&J`s combo extend patient` lives in study with AstraZeneca`s drug

    FIERCE PHARMA

    Hutchmed`s Priority Review For Orpathys-Tagrisso In Lung Cancer

    GLOBENEWSWIRE

    AstraZeneca India recasts biopharma unit

    ECONOMICTIMES

    Volumes spurt at Astrazeneca Pharma India Ltd counter

    BUSINESS STD

    What can AZ`s China probes teach other biopharma companies?

    FIERCE PHARMA

    Datopotamab Deruxtecan Application in EU is Voluntarily Withdrawn

    BUSINESSWIRE

    Achilles Announces Sale of Technology Assets to AstraZeneca

    GLOBENEWSWIRE

    AstraZeneca withdraws application for lung cancer drug in EU

    REUTERS

    LYNPARZA Demonstrates Prolonged Survival in Early Breast Cancer

    BUSINESSWIRE

    PureTech Presents LYT-200 Data for AML/MDS at ASH 2024

    BUSINESSWIRE

    Datopotamab Deruxtecan Gets Designation for EGFR-Mutated NSCLC

    BUSINESSWIRE

    Employees` LinkedIn likes land AstraZeneca and GSK in hot water

    FIERCE PHARMA

    IMFINZI® Granted Priority Review for Muscle-Invasive Bladder Cancer

    BUSINESSWIRE

    AstraZeneca, Daiichi share data behind Dato-DXd do-over

    FIERCE BIOTECH

    Pfizer’s Nurtec & Astrazeneca’s Breztri Top Digital Marketing Report

    BUSINESSWIRE

    Datopotamab Shows Clinical Activity in EGFR-Mutated Lung Cancer

    BUSINESSWIRE

    AstraZeneca chided after complainant targets senior staff

    FIERCE PHARMA

    AstraZeneca names exec to take on role of detained China head

    REUTERS

    FDA approves Imfinzi for limited-stage small cell lung cancer

    REUTERS

    AstraZeneca`s Biologic Imfinzi Receives Suppl Approval in US

    FDA

    AstraZeneca’s Enhertu Wins China Reimbursement Despite Probe

    BLOOMBERG

    AstraZeneca asthma drug more effective during attack than steroids

    REUTERS

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.